3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
2
Status
Completed
8
Terminated
2
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Breast Neoplasms
432
Carcinoma, Non-Small-Cell Lung
372
Neoplasms
324
Prostatic Neoplasms
244
Leukemia, Myeloid, Acute
230
Multiple Myeloma
229
Neoplasm Metastasis
215
Melanoma
201
Lung Neoplasms
178
Leukemia
172
Lymphoma
170
Colorectal Neoplasms
157
Pancreatic Neoplasms
151
Lymphoma, Non-Hodgkin
150
Recurrence
149
Ovarian Neoplasms
143
Leukemia, Lymphocytic, Chronic, B-Cell
134
Precursor Cell Lymphoblastic Leukemia-Lymphoma
131
Myelodysplastic Syndromes
121
Carcinoma, Renal Cell
120
Lymphoma, Large B-Cell, Diffuse
111
Lymphoma, Follicular
108
Brain Neoplasms
100
Squamous Cell Carcinoma of Head and Neck
96
Head and Neck Neoplasms
96
Glioblastoma
92
Urinary Bladder Neoplasms
88
Carcinoma, Hepatocellular
80
Hodgkin Disease
73
Colonic Neoplasms
73
Interventions
aflibercept
1
Oxaliplatin
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Terminated
×
Has results
×
Colorectal Cancer Metastatic
×
Clear all
NCT04550897
2026-05-13
BM7PE
Oslo University Hospital
Phase 1/2
Terminated
14 enrolled
14 charts
NCT01955629
2016-04-18
AMOR
Sanofi
Phase 1/2
Terminated
4 enrolled
7 charts